{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:07:40Z","timestamp":1771949260752,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Argentina de Microbiolog\u00eda"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ram.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:18:33Z","timestamp":1764332313000},"page":"83-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estrategias para el diagn\u00f3stico y monitoreo de citomegalovirus en pacientes trasplantados"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4103-2514","authenticated-orcid":false,"given":"Mar\u00eda Daniela","family":"Borgnia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Vanesa","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilina","family":"Rahhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Paula","family":"Eguiguren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Marti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de los \u00c1ngeles","family":"Baridon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Videla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ram.2025.10.006_bib0535","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcv.2016.07.001","article-title":"Nation-wide measure of variability in HCMV EBV and BKV DNA quantification among centers involved in monitoring transplanted patients","volume":"82","author":"Abbate","year":"2016","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0540","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcv.2011.08.005","article-title":"Cytomegalovirus DNA stability in EDTA anti-coagulated whole blood and plasma samples","volume":"52","author":"Abdul-Ali","year":"2011","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0545","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcv.2011.04.007","article-title":"Cytomegalovirus quantification; where to next in optimizing patient management?","volume":"51","author":"Atkinson","year":"2011","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0550","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: A phaseII study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ram.2025.10.006_bib0555","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0560","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11908-012-0292-2","article-title":"Cytomegalovirus in solid organ transplantation: Epidemiology, prevention, and treatment","volume":"14","author":"Beam","year":"2012","journal-title":"Curr Infect Dis Rep."},{"key":"10.1016\/j.ram.2025.10.006_bib0565","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.ram.2025.10.006_bib0570","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/infdis\/jix048","article-title":"Bronchoalveolar lavage DNA quantification in cytomegalovirus pneumonia after hematopoietic cell transplantation","volume":"215","author":"Boeckh","year":"2017","journal-title":"J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0575","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2011.03674.x","article-title":"Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: Pooled analysis of three clinical trials","volume":"11","author":"Brennan","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0580","year":"2022","journal-title":"UK guideline on prevention and management of cytomegalovirus (CMV) infection and disease following solid organ transplantation."},{"key":"10.1016\/j.ram.2025.10.006_bib0585","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2009-09-244145","article-title":"Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis","volume":"115","author":"Brown","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.ram.2025.10.006_bib0590","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0595","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/ajt.16450","article-title":"Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection","volume":"21","author":"Cassaniti","year":"2021","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105792","article-title":"Ganciclovir and maribavir cross-resistance revisited: relative drug susceptibilities of canonical cytomegalovirus mutants","volume":"222","author":"Chou","year":"2024","journal-title":"Antivir Res."},{"key":"10.1016\/j.ram.2025.10.006_bib0605","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jiz577","article-title":"Letermovir resistance analysis in a clinical trial of cytomegalovirus prophylaxis for hematopoietic stem cell transplant recipients","volume":"221","author":"Douglas","year":"2020","journal-title":"J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0610","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs."},{"key":"10.1016\/j.ram.2025.10.006_bib0615","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.2019000956","article-title":"How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation","volume":"135","author":"Einsele","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.ram.2025.10.006_bib0620","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/civ215","article-title":"Reduced mortality of cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices","volume":"61","author":"Erard","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0625","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4067\/S0716-10182011000200002","article-title":"Comparaci\u00f3n de las t\u00e9cnicas de reacci\u00f3n de polimerasa en cadena en tiempo real y antigenemia para la detecci\u00f3n de citomegalovirus en sangre de ni\u00f1os sometidos a trasplantes","volume":"28","author":"Farfan","year":"2011","journal-title":"Rev Chil Infectol."},{"key":"10.1016\/j.ram.2025.10.006_bib0630","first-page":"381","article-title":"Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: Predictive value of the immediate post-transplant assessment","volume":"25","author":"Fernandez-Ruiz","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.ram.2025.10.006_bib0635","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1600-6143.2011.03724.x","article-title":"Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation","volume":"11","author":"Gala-Lopez","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0640","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcv.2014.10.009","article-title":"Detection of cytomegalovirus (CMV) by real time PCR in fecal samples for non-invasive diagnosis of CMV intestinal disease","volume":"61","author":"Ganzenmueller","year":"2014","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0645","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/cid\/ciy295","article-title":"Absolute lymphocyte count: A predictor of recurrent cytomegalovirus disease in solid organ transplant recipients","volume":"67","author":"Gardiner","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0650","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/JCM.01499-07","article-title":"Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients","volume":"46","author":"Garrigue","year":"2008","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0655","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0660","doi-asserted-by":"crossref","first-page":"14021","DOI":"10.1111\/tid.14021","article-title":"Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir","volume":"25","author":"Gim\u00e9nez","year":"2023","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0665","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ram.2025.10.006_bib0670","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.bbmt.2012.05.015","article-title":"Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation","volume":"18","author":"Green","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0675","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: A retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ram.2025.10.006_bib0680","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0000000000004208","article-title":"Pharmacokinetics, safety, and efficacy of letermovir for cytomegalovirus prophylaxis in adolescent hematopoietic cell transplantation recipients","volume":"43","author":"Groll","year":"2024","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.ram.2025.10.006_bib0685","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/infdis\/jiz454","article-title":"Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: State of the evidence","volume":"221","author":"Haidar","year":"2020","journal-title":"J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0690","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for Transplant and Cellular Therapy Series: #3-Prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant Cell Ther."},{"key":"10.1016\/j.ram.2025.10.006_bib0695","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jmv.21996","article-title":"Algorithm based on CMV kinetic DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation","volume":"83","author":"Halfon","year":"2011","journal-title":"J Med Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0700","doi-asserted-by":"crossref","first-page":"e00782-20","DOI":"10.1128\/JCM.00782-20","article-title":"Persistent challenges of interassay variability in transplant viral load testing","volume":"58","author":"Hayden","year":"2020","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0705","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/JCM.02044-16","article-title":"Progress in quantitative viral load testing: Variability and impact of the WHO quantitative international standards","volume":"55","author":"Hayden","year":"2017","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0710","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/JCM.01287-11","article-title":"Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis","volume":"50","author":"Hayden","year":"2012","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0715","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4067\/s0716-10182023000400328","article-title":"Letermovir para prevenci\u00f3n de la infecci\u00f3n por citomegalovirus en receptores de trasplante alog\u00e9nico de progenitores hematopoy\u00e9ticos","volume":"40","author":"Herrera","year":"2023","journal-title":"Rev Chil Infectol."},{"key":"10.1016\/j.ram.2025.10.006_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4084\/MJHID.2024.039","article-title":"Letermovir primary cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients: Real-life data from a university hospital in Argentina","volume":"16","author":"Herrera","year":"2024","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0725","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM197511272932201","article-title":"The transplanted kidney as a source of cytomegalovirus infection","volume":"293","author":"Ho","year":"1975","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ram.2025.10.006_bib0730","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1600-6143.2005.00866.x","article-title":"A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0735","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0740","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/bmt.2017.11","article-title":"CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Iglesias","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0745","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40506-021-00253-w","article-title":"CMV infection in hematopoietic stem cell transplantation: Prevention and treatment strategies","volume":"13","author":"Jakharia","year":"2021","journal-title":"Curr Treat Options Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0750","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0755","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3343\/alm.2017.37.2.129","article-title":"Automated nucleic acid extraction systems for detecting cytomegalovirus and Epstein-Barr virus using real-time PCR: A comparison study between the QIAsymphony RGQ and QIAcube Systems","volume":"37","author":"Kim","year":"2017","journal-title":"Ann Lab Med."},{"key":"10.1016\/j.ram.2025.10.006_bib0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105623","article-title":"Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients","volume":"215","author":"Kleiboeker","year":"2023","journal-title":"Antivir Res."},{"key":"10.1016\/j.ram.2025.10.006_bib0765","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0770","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","article-title":"New insights on CMV management in solid organ transplant patients: Prevention, treatment, and management of resistant\/refractory disease","volume":"12","author":"Kotton","year":"2023","journal-title":"Infect Dis Ther."},{"key":"10.1016\/j.ram.2025.10.006_bib0775","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation."},{"key":"10.1016\/j.ram.2025.10.006_bib0780","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation."},{"key":"10.1016\/j.ram.2025.10.006_bib0785","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.bbmt.2018.03.005","article-title":"Cytomegalovirus and Epstein-Barr Virus DNA kinetics in whole blood and plasma of allogeneic hematopoietic stem cell transplantation recipients","volume":"24","author":"Lazzarotto","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0790","doi-asserted-by":"crossref","first-page":"e00043-19","DOI":"10.1128\/CMR.00043-19","article-title":"Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation","volume":"34","author":"Limaye","year":"2020","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.ram.2025.10.006_bib0795","first-page":"87","article-title":"Definitions of Cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2016","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0800","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies","volume":"25","author":"Ljungman","year":"2025","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0805","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/ciae321","article-title":"Consensus definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 update from the transplant associated virus infections forum","volume":"79","author":"Ljungman","year":"2024","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0810","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0815","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0820","first-page":"59","article-title":"Cytomegalovirus infections in transplant patients","volume":"100","author":"Ljungman","year":"1996","journal-title":"Scandinavian J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0825","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00041552-199611000-00009","article-title":"Mycophenolate mofetil in kidney transplantation","volume":"5","author":"Lui","year":"1996","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.1016\/j.ram.2025.10.006_bib0830","first-page":"361","article-title":"Use of everolimus-based immunosuppression to decrease cytomegalovirus infection after kidney transplant","volume":"14","author":"Malvezzi","year":"2016","journal-title":"Exp Clin Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0835","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: A multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0840","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1086\/598952","article-title":"An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants","volume":"199","author":"Manuel","year":"2009","journal-title":"J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0845","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ram.2025.10.006_bib0850","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: A phase3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0855","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/TP.0000000000002396","article-title":"Clinical correlation of cytomegalovirus infection with CMV-specific CD8+T-cell immune competence score and lymphocyte subsets in solid organ transplant recipients","volume":"103","author":"Meesing","year":"2018","journal-title":"Transplantation."},{"key":"10.1016\/j.ram.2025.10.006_bib0860","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs."},{"key":"10.1016\/j.ram.2025.10.006_bib0865","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/17512433.2018.1501557","article-title":"Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation","volume":"11","author":"Meesing","year":"2018","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.ram.2025.10.006_bib0870","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jcv.2012.01.002","article-title":"A new highly automated extraction system for quantitative real-time PCRs from whole blood samples: Routine monitoring of opportunistic infections in immunosuppressed patients","volume":"53","author":"Mengelle","year":"2012","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0875","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","article-title":"Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients","volume":"118","author":"Milano","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.ram.2025.10.006_bib0880","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/AJCPE5VZL1ONZHFJ","article-title":"Comparison of QIAGEN automated nucleic acid extraction methods for CMV quantitative PCR testing","volume":"133","author":"Miller","year":"2010","journal-title":"Am J Clin Pathol."},{"key":"10.1016\/j.ram.2025.10.006_bib0885","series-title":"Fields Virology","first-page":"2701","article-title":"Cytomegalovirus","author":"Mocarski","year":"2007"},{"key":"10.1016\/j.ram.2025.10.006_bib0890","series-title":"Biobanking: Methods and Protocols","article-title":"Nucleic acid extraction from human biological samples","author":"Mullegama","year":"1897"},{"key":"10.1016\/j.ram.2025.10.006_bib0895","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cix793","article-title":"Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: A systematic review and meta-analysis","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0900","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2017","article-title":"Going beyond serology for stratifying the risk of CMV infection in transplant recipients","volume":"29","author":"Navarro","year":"2019","journal-title":"Rev Med Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib0905","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JCM.42.3.1296-1297.2004","article-title":"Cytomegalovirus quantitation by real-time PCR is unaffected by delayed separation of plasma from whole blood","volume":"42","author":"Nesbitt","year":"2004","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0910","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tid.12601","article-title":"Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients","volume":"18","author":"Pascual","year":"2016","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0915","author":"Peinador","year":"2022","journal-title":"Aproximaci\u00f3n diagn\u00f3stica a la infecci\u00f3n por CMV"},{"key":"10.1016\/j.ram.2025.10.006_bib0920","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0213-005X(11)70052-0","article-title":"T\u00e9cnicas de monitorizaci\u00f3n de la infecci\u00f3n por citomegalovirus en los trasplantados de \u00f3rgano s\u00f3lido","volume":"29","author":"P\u00e9rez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.ram.2025.10.006_bib0925","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/infdis\/171.4.1014","article-title":"OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation","volume":"171","author":"Portela","year":"1995","journal-title":"J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0930","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","article-title":"Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts","volume":"20","author":"Raiola","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0935","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0940","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"Razonable","year":"2013","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.ram.2025.10.006_bib0945","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOT.0000000000000541","article-title":"Drug-resistant cytomegalovirus: clinical implications of specific mutations","volume":"23","author":"Razonable","year":"2018","journal-title":"Curr Opin Organ Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0950","series-title":"Red Nacional de Biobancos. Instituto de Salud CarlosIII","year":"2011"},{"key":"10.1016\/j.ram.2025.10.006_bib0955","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0960","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/pathogens11111384","article-title":"Whole blood versus plasma samples\u2014How does the type of specimen collected for testing affect the monitoring of cytomegalovirus viremia?","volume":"11","author":"Rzepka","year":"2022","journal-title":"Pathogens."},{"key":"10.1016\/j.ram.2025.10.006_bib0965","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0970","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1128\/JCM.38.9.3249-3253.2000","article-title":"False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation","volume":"38","author":"Schafer","year":"2000","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0975","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/IJPM.IJPM_946_20","article-title":"Experience of quantity and quality of DNA and RNA extraction from limited pediatric blood samples: A comparative analysis of automated and manual kit-based method","volume":"65","author":"Sharma","year":"2022","journal-title":"Indian J Pathol Microbiol."},{"key":"10.1016\/j.ram.2025.10.006_bib0980","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/bmt.2015.303","article-title":"Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood","volume":"51","author":"Solano","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib0985","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/jir722","article-title":"Cytomegalovirus survival on common environmental surfaces: Opportunities for viral transmission","volume":"205","author":"Stowell","year":"2012","journal-title":"J Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib0990","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.21873\/anticanres.14611","article-title":"Incidence of CMV replication and the role of letermovir primary\/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation-a single centre study","volume":"40","author":"Studer","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ram.2025.10.006_bib0995","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.bbmt.2019.07.016","article-title":"Quantitative PCR faster, more objective, and more reliable than immunohistochemistry for the diagnosis of Citomegalovirus gastrointestinal disease in allogeneic stem cell transplantation","volume":"25","author":"Suarez LLedo","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.ram.2025.10.006_bib1000","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.diagmicrobio.2015.12.008","article-title":"Comparative evaluation of whole blood versus plasma for quantitative detection of cytomegalovirus using an automated system","volume":"85","author":"Suganda","year":"2016","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib1005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/archinte.1977.03630200034012","article-title":"Primary and secondary cytomegalovirus infection","volume":"137","author":"Suwansirikul","year":"1977","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.ram.2025.10.006_bib1010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1157\/13089702","article-title":"Comparaci\u00f3n de dos t\u00e9cnicas de extracci\u00f3n de ADN para la cuantificaci\u00f3n de CMV en sangre","volume":"24","author":"Tang","year":"2006","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.ram.2025.10.006_bib1015","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: A CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.ram.2025.10.006_bib1020","unstructured":"Universidad de Salamanca. Banco Nacional de ADN CarlosIII. Programa de control de calidad de \u00e1cidos nucleicos. 3.a edici\u00f3n. Madrid, Espa\u00f1a, 2024."},{"key":"10.1016\/j.ram.2025.10.006_bib1025","year":"2020","journal-title":"Manual de Toma y Transporte de Muestras UVCLIN. Edici\u00f3n: 4.4"},{"key":"10.1016\/j.ram.2025.10.006_bib1030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2012.03.008","article-title":"Extraction of viral nucleic acids: Comparison of five automated nucleic acid extraction platforms","volume":"54","author":"Verheyen","year":"2012","journal-title":"J Clin Virol."},{"key":"10.1016\/j.ram.2025.10.006_bib1035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ofid\/ofac687","article-title":"Real-world outcomes associated with letermovir use for cytomegalovirus primary prophylaxis in allogeneic hematopoietic cell transplant recipients: A systematic review and meta-analysis of observational studies","volume":"10","author":"Vyas","year":"2023","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.ram.2025.10.006_bib1040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/oxfordjournals.aje.a121347","article-title":"Seroepidemiology of infections due to members of the herpes virus group","volume":"94","author":"Wentworth","year":"1971","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.ram.2025.10.006_bib1045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"Witzke","year":"2012","journal-title":"Transplantation."},{"key":"10.1016\/j.ram.2025.10.006_bib1050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jviromet.2014.05.024","article-title":"Effects of storage time on cytomegalovirus DNA stability in plasma determined by quantitative real-time PCR","volume":"207","author":"Xie","year":"2014","journal-title":"J Virol Methods."},{"key":"10.1016\/j.ram.2025.10.006_bib1055","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/bjh.19451","article-title":"Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation","volume":"204","author":"Yan","year":"2024","journal-title":"Br J Haematol."},{"key":"10.1016\/j.ram.2025.10.006_bib1060","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1600-6143.2004.00571.x","article-title":"Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant."}],"container-title":["Revista Argentina de Microbiolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125001087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754125001087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:44:25Z","timestamp":1771947865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0325754125001087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0325754125001087"],"URL":"https:\/\/doi.org\/10.1016\/j.ram.2025.10.006","relation":{},"ISSN":["0325-7541"],"issn-type":[{"value":"0325-7541","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrategias para el diagn\u00f3stico y monitoreo de citomegalovirus en pacientes trasplantados","name":"articletitle","label":"Article Title"},{"value":"Revista Argentina de Microbiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ram.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Argentina de Microbiolog\u00eda.","name":"copyright","label":"Copyright"}]}}